Skip to main content

Table 1 Baseline characteristics of patients with breast carcinoma

From: Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma

Indicators Group A (n = 10) Group B (n = 10) P value
Mean age (n)    0.972
 ≤60 years 7 7  
 >60 years 3 3  
Lymph node metastasis (n)    0.881
 0 2 2  
 ≤3 3 4  
 >3 5 4  
Molecular subtypes (n)    0.639
 Luminal A 3 4  
 Luminal B 7 6  
 HER-2 0 0  
 Triple negative 0 0  
Tumor staging (n)    0.043
 I 3 0  
 II 2 7  
 III 5 3  
Tumor size (cm)    <0.001
 ≤2 cm 10 2  
 >2 cm 0 8  
Pathological classification (n)    0.136
 IDC stage I 0 2  
 IDC stage II 10 8  
 Poorly differentiated adenocarcinoma 0 0  
 Adenocarcinoma 0 0  
 Metastatic adenocarcinoma 0 0  
  1. Group A, primary breast carcinoma with recurrent metastasis during the follow-up; Group B, primary breast carcinoma with no pathological evidence of recurrence or metastasis; stage I, T1N0M0; stage II, T0-1N1M0, T2N0-1M0, and T3N0M0; stage III, T0-2N2M0, T3N1-2M0, T4N0-3M0, and T0-4N3M0; IDC, infiltrating duct carcinoma. P < 0.5 was considered statistically significant